Ultimately, the evidence supports MMP9 as a critical mediator in CRC, aiding tumor invasion and metastasis, and its increased activity due to chemotherapy is suggested as a potential risk for developing CIPN. The gene discussed is MMP9; the disease is colorectal carcinoma.